


Ask a doctor about a prescription for Seroxat
Paroxetine
Anxiety disorders for which Seroxat is used include: obsessive-compulsive disorder (recurring, obsessive thoughts with uncontrolled behavior), panic disorder (panic attacks, including those caused by agoraphobia, which is a fear of open spaces), social phobia (fear or avoidance of social situations), post-traumatic stress disorder (anxiety caused by a traumatic event), generalized anxiety disorder (generalized feeling of anxiety or nervousness). Seroxat belongs to a group of medicines called selective serotonin reuptake inhibitors (SSRIs). It is not fully understood how Seroxat and other SSRIs work, but they may increase the level of serotonin in the brain. Proper treatment of depression and anxiety disorders is important for the patient to feel better.
If the answer is YES to any of the above questionsand the patient has not yet consulted their doctor, they should go back to their doctorand ask how to take Seroxat.
Patients under 18 years old are at increased risk of side effects such as suicidal attempts, suicidal thoughts, and hostility (especially aggression, rebellious behavior, and anger). If the doctor has prescribed Seroxat to a patient under 18 years old and there are concerns, the patient should contact their doctor. If these symptoms occur or worsen while taking Seroxat, the patient should inform their doctor. Additionally, there is currently no data on the long-term safety of Seroxat regarding growth, maturation, and cognitive and behavioral development in this age group. In studies of Seroxat in patients under 18 years old, common side effects that occurred with a frequency of less than 1 in 10 were: increased suicidal thoughts and attempts, intentional self-harm, hostility, aggressive behavior, or unfriendly behavior, loss of appetite, tremors, abnormal sweating, excessive activity (excess energy), restlessness, emotional instability (including tearfulness and mood changes), and unusual bruising or bleeding (such as nosebleeds). These studies also showed that such symptoms occurred, although less frequently, in children and adolescents taking placebo tablets instead of Seroxat. Some patients under 18 years old in these studies experienced withdrawal symptoms from Seroxat. These symptoms were very similar to those observed in adults after stopping Seroxat (see section 3). Additionally, in patients under 18 years old, abdominal pain, irritability, and emotional instability (including tearfulness, mood changes, self-harm, suicidal thoughts, and attempts) also occurred frequently (with a frequency of less than 1 in 10).
In patients with depression and/or anxiety disorders, suicidal thoughts or self-harm may sometimes occur. They may be more frequent at the beginning of antidepressant treatment, as it may take some time, usually about two weeks, for the medicines to start working, and sometimes even longer. In patientssuch thoughts may occur more frequently:
In some patients taking Seroxat, a condition called akathisia may develop. They feel anxious and cannot sit or stand still. In other patients, a condition called serotonin syndrome or malignant neuroleptic syndrome may occur, in which patients have some or all of the following symptoms: feeling highly agitated or irritated, feeling confused, feeling anxious, fever, sweating, trembling, chills, hallucinations (strange visions or hearing strange sounds), muscle stiffness, sudden muscle contractions, or rapid heartbeat. The symptoms may worsen, leading to loss of consciousness. If the patient notices any of these symptoms, they should contact their doctor. More information about these or other side effects of Seroxat can be found in section 4. Medicines like Seroxat (SSRIs) may cause sexual function disorders (see section 4). In some cases, these symptoms persisted after treatment was stopped.
Some medicines may affect the action of Seroxat or increase the risk of side effects. Seroxat may also affect the action of other medicines. These medicines include:
If the patient is currently taking or has recently taken any of these medicinesand has not yet discussed this with their doctor, they should contact their doctor againand ask how to proceed. The dose of the medicine may need to be changed or a different medicine may need to be taken.
have recently taken, as well as any medicines they plan to take, including those that are available without a prescription.
During Seroxat treatment, the patient should not drink alcohol. Alcohol may increase the symptoms of the disease or side effects. Taking Seroxat in the morning, during a meal, reduces the likelihood of nausea.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine. There are reports suggesting that children whose mothers took Seroxat during the first few months of pregnancy may have congenital malformations, particularly heart defects. In the general population, about 1 in 100 children is born with a heart defect. This number increases to 2 in 100 children if the mother takes Seroxat. The doctor will decide together with the patient whether it is better for the patient to switch to a different medicine or gradually stop taking Seroxat during pregnancy. In some cases, the doctor may also suggest that it is better for the patient to continue taking Seroxat. The patient should ensure that their midwife or doctor is informed that they are taking Seroxat. Taking Seroxat at the end of pregnancy may increase the risk of severe bleeding from the vagina, which occurs shortly after delivery, especially if the patient has a history of bleeding disorders. If the patient is taking Seroxat, they should inform their doctor or midwife so that they can provide appropriate advice. Medicines like Seroxat taken during pregnancy, especially in the last few months, may increase the risk of a condition called persistent pulmonary hypertension in the newborn (PPHN). In PPHN, the blood pressure in the blood vessels between the heart and lungs is too high. If the patient takes Seroxat during the last 3 months of pregnancy, the newborn may also experience other symptoms, usually within the first 24 hours after birth, including:
Seroxat may pass into breast milk in very small amounts. If the patient is taking Seroxat, they should consult their doctor before breastfeeding. The doctor and patient can decide together whether to breastfeed while taking Seroxat. In animal studies, paroxetine has been shown to reduce sperm quality. This could theoretically affect fertility, but the impact on human fertility has not been determined.
Possible side effects of Seroxat include dizziness, disorientation, drowsiness, and vision disturbances. If the patient experiences any of these side effects, they should not drive or operate machinery.
This medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is essentially "sodium-free".
This medicine should always be taken as directed by the doctor. If the patient has any doubts, they should consult their doctor or pharmacist. Sometimes taking one tablet does not ensure that the patient takes the full recommended dose of the medicine. The following table indicates how many Seroxat tablets the patient should take for a given dose.
10 mg half a tablet 20 mg one tablet 30 mg one and a half tablets 40 mg two tablets 50 mg two and a half tablets 60 mg three tablets The usual doses used for different conditions are listed below. The doctor will advise the patient on which dose to start with. Most patients start to feel better after a few weeks. If the patient does not feel better after this time, they should consult their doctor. The doctor may decide to gradually increase the dose by 10 mg until the maximum daily dose is reached.
The doctor will discuss with the patient how long they should take the tablets. Treatment may last for several months or even longer.
The maximum dose for patients over 65 years old is 40 mg per day.
In patients with liver disease or severe kidney disease, the doctor may recommend a lower dose of Seroxat than usual.
The patient should never take more tablets than prescribed by their doctor. If the patient (or someone else) has taken too many Seroxat tablets, they should immediately inform their doctor or contact the nearest emergency department. They should show them the packaging of the tablets. As a result of overdosing on Seroxat, the patient may experience side effects described in section 4: Possible side effectsor the following symptoms: fever, involuntary muscle contractions.
The medicine should be taken at the same time every day. If the patient misses a dose and remembers before going to bed, they should take it immediately. The next day, they should take the dose as usual. If the patient remembers in the night or the next day that they missed a dose, they should not take the missed dose. The patient may experience withdrawal symptoms, but they should resolve quickly after taking the next dose at the usual time. The patient should not take a double dose to make up for the missed dose.
Seroxat does not relieve symptoms immediately- all antidepressant medicines start working after some time. Some patients start to feel better after a few weeks, and others later. Some patients taking antidepressants feel worse before they start to feel better. If the patient does not feel better after a few weeks of treatment, they should consult their doctor for advice. The doctor should recommend that the patient have a follow-up visit after a few weeks of starting to take the medicine for the first time. The patient should inform their doctor if they do not start to feel better.
When stopping Seroxat, the doctor will help the patient gradually reduce the dose over a few weeks or months - this should limit the possibility of withdrawal symptoms. One way to do this is to gradually decrease the dose of Seroxat by 10 mg per week. In most patients, withdrawal symptoms are mild and resolve on their own within two weeks. In some patients, symptoms may be more severe or may last longer. If the patient experiences withdrawal symptoms after stopping Seroxat, the doctor may decide that the patient should stop taking the medicine more slowly. If the patient experiences severe symptoms during Seroxat withdrawal, they should contact their doctor. The doctor may recommend restarting the tablets and stopping them more slowly.
Studies show that 3 out of 10 patients notice one or more withdrawal symptoms when stopping Seroxat treatment. Some of these symptoms occur more frequently than others.
In case of any further doubts about taking this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Seroxat can cause side effects, although not everybody gets them. Side effects are more common during the first few weeks of taking Seroxat.
It may be necessary to contact the doctor or the nearest emergency department immediately.
Side effects with unknown frequency(frequency cannot be estimated from the available data)
Side effects with unknown frequency(frequency cannot be estimated from the available data);
In some patients taking Seroxat, ringing, buzzing, whistling, or other persistent noises in the ears (tinnitus) have occurred during treatment. In patients taking medicines like Seroxat, an increased risk of bone fractures has been observed.
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety, Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych, Al. Jerozolimskie 181C, 02-222 Warsaw, phone: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. By reporting side effects, more information can be collected on the safety of the medicine.
The medicine should be stored out of sight and reach of children. Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated. Do not store above 30°C. Store in the original packaging to protect from light. If the patient is taking half-tablets, they should be careful to store them in the medicine packaging. Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of Seroxat is paroxetine (20 mg) in the form of paroxetine hydrochloride hemihydrate. The other ingredients of the medicine are: Tablet core: calcium hydrogen phosphate dihydrate, magnesium stearate, sodium carboxymethylcellulose (type A). Tablet coating: hypromellose, titanium dioxide (E 171), macrogol 400, polysorbate 80.
Seroxat, 20 mg, coated tablets - white, oval, biconvex, coated tablets with the inscription "SEROXAT 20" or "20" on one side and a score line on the other side. Each pack of Seroxat, 20 mg, coated tablets contains 30 tablets in child-resistant blisters. For more detailed information, the patient should contact the marketing authorization holder or the parallel importer.
GlaxoSmithKline Trading Services Limited 12 Riverwalk Citywest Business Campus Dublin 24, Ireland
Delpharm Poznań Spółka Akcyjna ul. Grunwaldzka 189 60-322 Poznań Poland
InPharm Sp. z o.o. ul. Strumykowa 28/11 03-138 Warsaw
InPharm Sp. z o.o. Services sp. k. ul. Chełmżyńska 249 04-458 Warsaw Marketing authorization number in Croatia, the country of export:HR-H-051250245-01 Parallel import authorization number:423/21
| This medicine is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names: | |
| Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, United Kingdom (Northern Ireland) | Seroxat |
| France | Deroxat |
It may be helpful for the patient to contact a support group or patient organization, where they can learn more about their condition. The doctor can provide more detailed information. Date of leaflet approval: 01.02.2023[Information about the trademark]
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Seroxat – subject to medical assessment and local rules.